Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03065179
Title Trial of SBRT in Combination With Nivolumab/Ipilimumab in RCC / Kidney Cancer Patients
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Texas Southwestern Medical Center
Indications

renal cell carcinoma

Therapies

Ipilimumab + Nivolumab

Age Groups: adult | senior | child
Covered Countries USA


No variant requirements are available.